/Investor DB

Graphite Ventures — 2024 Investments

5 investments dated 2024 · listed companies and verified rows first · show all

Cognito Healthcognitohealth.cominMar 2024 · $2M

Cognito Health is a medical device manufacturer that uses predictive algorithms to provide contact-free patient monitoring, forecasting adverse events such as falls and pressure injuries before they occur.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Co-investorsNSG VenturesGarage CapitalInovia CapitalSimplex VenturesSpring Impact CapitalStandUp Ventures

InfinitySPMinfinityspm.comJun 2024

infinitySPM is a OneStream-based software development partner solution for enterprises to manage sales operations, incentive compensation, and sales performance planning.

AI & Machine LearningEnterprise SoftwareSaaSSales Tech

Frank Pizzolato(Founder)

Co-investorsInovia Capital

Protexxaprotexxa.comin𝕏Jul 2024 · $7.2M

Protexxa Defender is a platform that continuously monitors organizations for cybersecurity risks, threats, and vulnerabilities, providing personalized recommendations to individuals and organization-wide insights to reduce attack surface.

AI & Machine LearningCybersecurityEnterprise SoftwareSaaS

Joseph L.(Managing Director of Global Consulting)

Co-investorsBKR CapitalSandpiper VenturesBell VenturesThe Firehood

Scribenotescribenote.cominJun 2024

Scribenote provides AI-powered clinical documentation software for veterinary professionals to automate note-taking and reduce administrative workload.

AI & Machine LearningHealthtechSaaSKitchener, CA

Dr. Katie(Veterinary Lead, Co-founder)Alina Pavel(Secretary and Chief Product Officer)inRyan Gallagher(Chief Executive Officer)inDr. Emily(Marketing, Co-founder)inDr. Emily Merry(Founder)in

Co-investorsAndreessen HorowitzInovia Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Basetwo Artificial Intelligence

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.